Repare Therapeutics
Dr. Frank Sicheri is a Senior Investigator at the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital and Professor in the Departments of Molecular Genetics and Biochemistry at the University of Toronto. His research focuses on the structural biology of eukaryotic signaling with specific interests in the protein kinase superfamily and the ubiquitin proteolytic system.
His lab made important contributions to understanding normal signaling mechanisms, mechanisms of dysregulation that contribute to disease, and mechanisms of drug action and resistance. He is the recipient of numerous awards and honours including election as a Royal Society of Canada Fellow, the Merck Frosst Prize, Canada Research Chair in Signal Transduction, and Terry Fox Young Investigator Scholar.
Dr. Frank Sicheri holds a B.Sc. and Ph.D. in Biochemistry from McMaster University. He received his post-doctoral training at Rockefeller University under the mentorship of Dr. John Kuriyan.
This person is not in the org chart
This person is not in any offices
Repare Therapeutics
Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.